Zoi Liakouli

National and Kapodistrian University of Athens

Papers

Total Citations

H-Index

About

Zoi Liakouli is a clinical researcher whose work focuses on advancing non-invasive cancer treatments, particularly through stereotactic ablative radiotherapy (SABR) for early-stage lung cancer. Her most cited study, a 2024 interim analysis of robotic SABR, addresses a critical gap in oncology: providing effective, non-surgical options for patients who are medically inoperable or decline surgery. By evaluating outcomes in this vulnerable population, Liakouli’s research contributes to the growing evidence that SABR can achieve tumor control with minimal toxicity, offering a compelling alternative to invasive procedures. Her work underscores the potential of robotic precision to improve both survival and quality of life. With 2 citations already, this study is gaining traction as a practical reference for clinicians and researchers exploring radiotherapy innovations. Liakouli’s contributions are particularly relevant in an era where personalized, less invasive therapies are transforming cancer care, and her findings help shape protocols for lung cancer management. Her dedication to refining SABR techniques highlights her role in bridging the gap between surgical and radiotherapeutic approaches, making her a promising voice in radiation oncology.